The current and ongoing COVID-19 pandemic has created many disruptions and is changing current practices of businesses and organisations all around the world. In this webinar, panelists from around Australia will facilitate an engaging and exciting discussion to dive deep and explore how COVID-19 is affecting Anatomical Pathology laboratories and the possible changes to business practice and operation that will result from this in the post COVID-19 world.
Topics being discussed include:
– How has COVID-19 impacted Anatomical Pathology labs?
– How have Anatomical Pathology labs adapted to the challenges presented with COVID-19?
– What opportunities to drive digital innovation has COVID-19 presented?
– Additional demands being placed on Pathologists to participate in multidisciplinary teams.
– What will the downturn in Pathology testing during COVID-19 mean for Anatomical Pathology labs and Oncology patients moving forward?
– Interactive Q&A session regarding Anatomical Pathology with an expert panel.
Panelists
Simon Nazaretian, Australian Clinical Labs, Melbourne (panel chair)
Chris Douglas, Histopath Diagnostic Specialists, Sydney
Mikkaela McCormack, Dorevitch Pathology, Melbourne
Jeremy Parry, Western Diagnostics Pathology and DLS Pathology, Perth
Cameron Snell, The Mater Hospital, Brisbane
Key reasons to attend?
– Gain insights from the sharing of pathologists from all across Australia.
– Do you have questions about Anatomical Pathology before, during and after COVID-19? Ask the experts during the live Q&A session.
This webinar is proudly brought to you by DHCRC, Curtin University and La Trobe University in partnership with Roche.
